Johnson Brady 4
4 · Cidara Therapeutics, Inc. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
Johnson Brady
Dir. of Finance & Controller
Transactions
- Sale
Common Stock
2022-03-21$0.81/sh−654$530→ 49,366 total
Footnotes (1)
- [F1]The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.